AG
ALT icon

Advisor Group’s Altimmune ALT Stock Holding History

Advisor Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$16K Buy
8,300
+1,100
+15% +$2.03K ﹤0.01% 4069
2019
Q3 		$14K Buy
+7,200
New +$16K ﹤0.01% 4154
2017
Q4 		– Sell
-12
Closed -$1K – 4940
2017
Q3 		$1K Buy
12
+11
+1,100% +$819 ﹤0.01% 4646
2017
Q2 		$0 Buy
+1
New +$166 ﹤0.01% 4772

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advisor Group's ALT Position: Q4 2019 in Review

Advisor Group increased its Altimmune (ALT) stake by 15% in Q4 2019, buying an estimated $2.03K and bringing the position to 8,300 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #4069.

Advisor Group first reported a position in ALT in Q2 2017 and has held it in 4 quarters since. 28 funds tracked by Wall St. Rank hold ALT as of Q4 2019.

  • Advisor Group held 8,300 shares of Altimmune worth $16K as of Q4 2019.
  • Advisor Group bought 1,100 Altimmune shares in Q4 2019, an estimated $2.03K.
  • Altimmune made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4069 holding.
  • Advisor Group first reported a position in Altimmune in Q2 2017 and has held it in 4 quarters since.
  • 28 funds tracked by Wall St. Rank held Altimmune as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.